Artelo Biosciences在日本获得Art27.13预期商业配方专利授权的核准通知

美股速递
Aug 20

Artelo Biosciences已成功获得日本专利局对其Art27.13预期商业配方专利权利要求发出的核准通知。这一关键进展标志着公司在国际知识产权布局上再下一城,为其核心候选药物的商业化道路扫清了重要障碍。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10